vs
MP Materials Corp.（MP）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是MP Materials Corp.的1.4倍（$75.5M vs $52.7M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -13.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-109.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 4.0%）
MP Materials Corp.是总部位于美国的稀土材料生产商，拥有并运营加利福尼亚州芒廷帕斯矿，这是西半球唯一在产的稀土开采及加工设施，所产核心材料可广泛应用于电动汽车、风力发电机、国防工业等多个关键领域。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MP vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$52.7M
营收增速更快
PBYI
高出41.3%
-13.6%
自由现金流更多
PBYI
多$123.6M
$-109.3M
两年增速更快
PBYI
近两年复合增速
4.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $52.7M | $75.5M |
| 净利润 | $9.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -7.0% | 22.7% |
| 净利率 | 17.9% | — |
| 营收同比 | -13.6% | 27.7% |
| 净利润同比 | 142.2% | — |
| 每股收益（稀释后） | $0.07 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MPPBYI
| Q4 25 | $52.7M | $75.5M | ||
| Q3 25 | $53.6M | $54.5M | ||
| Q2 25 | $57.4M | $52.4M | ||
| Q1 25 | $60.8M | $46.0M | ||
| Q4 24 | $61.0M | $59.1M | ||
| Q3 24 | $62.9M | $80.5M | ||
| Q2 24 | $31.3M | $47.1M | ||
| Q1 24 | $48.7M | $43.8M |
净利润MPPBYI
| Q4 25 | $9.4M | — | ||
| Q3 25 | $-41.8M | $8.8M | ||
| Q2 25 | $-30.9M | $5.9M | ||
| Q1 25 | $-22.6M | $3.0M | ||
| Q4 24 | $-22.3M | — | ||
| Q3 24 | $-25.5M | $20.3M | ||
| Q2 24 | $-34.1M | $-4.5M | ||
| Q1 24 | $16.5M | $-4.8M |
毛利率MPPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率MPPBYI
| Q4 25 | -7.0% | 22.7% | ||
| Q3 25 | -125.2% | 17.6% | ||
| Q2 25 | -76.5% | 12.7% | ||
| Q1 25 | -57.2% | 8.7% | ||
| Q4 24 | -72.1% | 22.6% | ||
| Q3 24 | -62.8% | 27.4% | ||
| Q2 24 | -171.1% | -4.6% | ||
| Q1 24 | -66.6% | -5.3% |
净利率MPPBYI
| Q4 25 | 17.9% | — | ||
| Q3 25 | -78.0% | 16.2% | ||
| Q2 25 | -53.8% | 11.2% | ||
| Q1 25 | -37.2% | 6.5% | ||
| Q4 24 | -36.6% | — | ||
| Q3 24 | -40.5% | 25.2% | ||
| Q2 24 | -108.9% | -9.6% | ||
| Q1 24 | 33.9% | -11.0% |
每股收益（稀释后）MPPBYI
| Q4 25 | $0.07 | $0.26 | ||
| Q3 25 | $-0.24 | $0.17 | ||
| Q2 25 | $-0.19 | $0.12 | ||
| Q1 25 | $-0.14 | $0.06 | ||
| Q4 24 | $-0.12 | $0.40 | ||
| Q3 24 | $-0.16 | $0.41 | ||
| Q2 24 | $-0.21 | $-0.09 | ||
| Q1 24 | $-0.08 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $97.5M |
| 总债务越低越好 | $998.7M | $22.7M |
| 股东权益账面价值 | $2.0B | $130.3M |
| 总资产 | $3.9B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.50× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MPPBYI
| Q4 25 | $1.2B | $97.5M | ||
| Q3 25 | $1.1B | $94.4M | ||
| Q2 25 | $261.5M | $96.0M | ||
| Q1 25 | $198.3M | $93.2M | ||
| Q4 24 | $282.4M | $101.0M | ||
| Q3 24 | $284.4M | $96.7M | ||
| Q2 24 | $295.6M | $96.8M | ||
| Q1 24 | $296.5M | $107.2M |
总债务MPPBYI
| Q4 25 | $998.7M | $22.7M | ||
| Q3 25 | $997.3M | $34.0M | ||
| Q2 25 | $910.8M | $45.3M | ||
| Q1 25 | $909.8M | $56.7M | ||
| Q4 24 | $908.7M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益MPPBYI
| Q4 25 | $2.0B | $130.3M | ||
| Q3 25 | $2.0B | $115.3M | ||
| Q2 25 | $1.0B | $104.7M | ||
| Q1 25 | $1.0B | $97.1M | ||
| Q4 24 | $1.1B | $92.1M | ||
| Q3 24 | $1.1B | $71.1M | ||
| Q2 24 | $1.1B | $48.5M | ||
| Q1 24 | $1.1B | $51.0M |
总资产MPPBYI
| Q4 25 | $3.9B | $216.3M | ||
| Q3 25 | $3.8B | $202.9M | ||
| Q2 25 | $2.3B | $194.9M | ||
| Q1 25 | $2.4B | $196.2M | ||
| Q4 24 | $2.3B | $213.3M | ||
| Q3 24 | $2.3B | $220.7M | ||
| Q2 24 | $2.4B | $205.0M | ||
| Q1 24 | $2.4B | $214.1M |
负债/权益比MPPBYI
| Q4 25 | 0.50× | 0.17× | ||
| Q3 25 | 0.51× | 0.30× | ||
| Q2 25 | 0.90× | 0.43× | ||
| Q1 25 | 0.88× | 0.58× | ||
| Q4 24 | 0.86× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-46.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-109.3M | $14.4M |
| 自由现金流率自由现金流/营收 | -207.4% | 19.1% |
| 资本支出强度资本支出/营收 | 118.5% | 0.0% |
| 现金转化率经营现金流/净利润 | -4.97× | — |
| 过去12个月自由现金流最近4个季度 | $-328.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流MPPBYI
| Q4 25 | $-46.9M | $14.4M | ||
| Q3 25 | $-42.0M | $9.7M | ||
| Q2 25 | $-3.7M | $14.1M | ||
| Q1 25 | $-63.2M | $3.6M | ||
| Q4 24 | $30.5M | $15.6M | ||
| Q3 24 | $-6.8M | $11.0M | ||
| Q2 24 | $30.8M | $1.0M | ||
| Q1 24 | $-41.1M | $11.2M |
自由现金流MPPBYI
| Q4 25 | $-109.3M | $14.4M | ||
| Q3 25 | $-92.5M | $9.7M | ||
| Q2 25 | $-32.7M | $14.1M | ||
| Q1 25 | $-93.7M | $3.6M | ||
| Q4 24 | $-11.2M | $15.6M | ||
| Q3 24 | $-53.3M | $11.0M | ||
| Q2 24 | $-15.6M | $1.0M | ||
| Q1 24 | $-93.0M | — |
自由现金流率MPPBYI
| Q4 25 | -207.4% | 19.1% | ||
| Q3 25 | -172.8% | 17.7% | ||
| Q2 25 | -56.9% | 26.8% | ||
| Q1 25 | -154.0% | 7.7% | ||
| Q4 24 | -18.3% | 26.4% | ||
| Q3 24 | -84.7% | 13.7% | ||
| Q2 24 | -50.1% | 2.1% | ||
| Q1 24 | -191.0% | — |
资本支出强度MPPBYI
| Q4 25 | 118.5% | 0.0% | ||
| Q3 25 | 94.3% | 0.0% | ||
| Q2 25 | 50.5% | 0.0% | ||
| Q1 25 | 50.1% | 0.1% | ||
| Q4 24 | 68.3% | 0.0% | ||
| Q3 24 | 73.8% | 0.0% | ||
| Q2 24 | 148.7% | 0.0% | ||
| Q1 24 | 106.5% | 0.0% |
现金转化率MPPBYI
| Q4 25 | -4.97× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MP
| Materials Segment | $35.6M | 68% |
| Other | $17.1M | 32% |
PBYI
暂无分部数据
